Artemis Medicare Services Ltd
Artemis Medicare Services Ltd (AMSL) was incorporated on 2004, by the promoters of the Apollo Tyres Group, is engaged in healthcare business. AMSL operates a 541-bedded multi-specialty tertiary care hospital in Gurgaon. The specialty areas for AMSL include Orthopaedics, Oncology, Cardiovascular, Neurosciences and Bariatric & Minimally Invasive Surgery. ASML has been awarded with the NABH and JCI accreditation. AMSL has also diversified its presence through Artemis Daffodil , Artemis Lite, Artemis Cardiac Care and Artemis Solace models. [1][2]
- Market Cap ₹ 3,308 Cr.
- Current Price ₹ 238
- High / Low ₹ 350 / 208
- Stock P/E 37.6
- Book Value ₹ 61.2
- Dividend Yield 0.19 %
- ROCE 14.9 %
- ROE 12.9 %
- Face Value ₹ 1.00
Pros
- Company has delivered good profit growth of 32.5% CAGR over last 5 years
Cons
- Stock is trading at 3.89 times its book value
- Promoter holding has decreased over last quarter: -0.64%
- Company has a low return on equity of 11.7% over last 3 years.
- Promoters have pledged or encumbered 44.5% of their holding.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Healthcare Services Hospital
Part of BSE Healthcare BSE SmallCap BSE Allcap
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
261 | 368 | 402 | 459 | 503 | 547 | 563 | 402 | 545 | 714 | 845 | 913 | 946 | |
234 | 325 | 359 | 406 | 442 | 480 | 501 | 367 | 477 | 620 | 717 | 763 | 791 | |
Operating Profit | 27 | 43 | 43 | 53 | 60 | 66 | 62 | 35 | 68 | 94 | 128 | 150 | 155 |
OPM % | 11% | 12% | 11% | 11% | 12% | 12% | 11% | 9% | 12% | 13% | 15% | 16% | 16% |
1 | 3 | 5 | 4 | 3 | 2 | 4 | 7 | 3 | 7 | 7 | 33 | 35 | |
Interest | 13 | 12 | 9 | 9 | 9 | 11 | 13 | 12 | 11 | 19 | 30 | 30 | 30 |
Depreciation | 9 | 12 | 12 | 15 | 18 | 20 | 22 | 21 | 21 | 29 | 38 | 43 | 43 |
Profit before tax | 7 | 21 | 27 | 32 | 35 | 37 | 32 | 9 | 39 | 53 | 68 | 109 | 117 |
Tax % | 0% | 12% | 21% | 16% | 24% | 44% | 36% | 20% | 16% | 25% | 28% | 24% | |
7 | 19 | 22 | 27 | 27 | 21 | 20 | 7 | 33 | 40 | 49 | 83 | 88 | |
EPS in Rs | 0.32 | 0.88 | 1.03 | 1.29 | 1.27 | 0.98 | 1.54 | 0.54 | 2.46 | 2.96 | 3.62 | 6.07 | 6.38 |
Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 15% | 12% | 7% |
Compounded Sales Growth | |
---|---|
10 Years: | 10% |
5 Years: | 10% |
3 Years: | 19% |
TTM: | 10% |
Compounded Profit Growth | |
---|---|
10 Years: | 16% |
5 Years: | 32% |
3 Years: | 36% |
TTM: | 57% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | 70% |
3 Years: | 62% |
1 Year: | -11% |
Return on Equity | |
---|---|
10 Years: | 10% |
5 Years: | 10% |
3 Years: | 12% |
Last Year: | 13% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 21 | 21 | 21 | 21 | 21 | 0.00 | 13 | 13 | 13 | 13 | 14 | 14 |
Reserves | 116 | 135 | 163 | 183 | 210 | 280 | 301 | 308 | 348 | 393 | 438 | 828 |
110 | 85 | 68 | 94 | 91 | 114 | 108 | 137 | 190 | 268 | 305 | 280 | |
66 | 90 | 93 | 124 | 130 | 160 | 159 | 130 | 145 | 207 | 191 | 221 | |
Total Liabilities | 313 | 331 | 345 | 422 | 452 | 555 | 581 | 589 | 697 | 882 | 948 | 1,343 |
236 | 239 | 249 | 283 | 309 | 381 | 387 | 372 | 476 | 584 | 699 | 729 | |
CWIP | 0 | 0 | 1 | 27 | 43 | 49 | 56 | 81 | 64 | 95 | 33 | 40 |
Investments | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 4 | 6 | 12 | 15 | 15 |
77 | 91 | 94 | 112 | 100 | 124 | 137 | 132 | 152 | 192 | 200 | 559 | |
Total Assets | 313 | 331 | 345 | 422 | 452 | 555 | 581 | 589 | 697 | 882 | 948 | 1,343 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
45 | 53 | 20 | 58 | 72 | 41 | 56 | 27 | 61 | 129 | 108 | 139 | |
-12 | -10 | -14 | -74 | -67 | -50 | -22 | -34 | -106 | -153 | -90 | -388 | |
-21 | -35 | -24 | 19 | -10 | 14 | -33 | 13 | 44 | 30 | -26 | 277 | |
Net Cash Flow | 11 | 7 | -18 | 3 | -4 | 5 | 2 | 6 | -2 | 7 | -8 | 28 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 41 | 39 | 49 | 48 | 40 | 52 | 50 | 48 | 47 | 43 | 36 | 37 |
Inventory Days | 26 | 26 | 21 | 19 | ||||||||
Days Payable | 237 | 195 | 189 | 187 | ||||||||
Cash Conversion Cycle | -171 | -129 | -120 | -120 | 40 | 52 | 50 | 48 | 47 | 43 | 36 | 37 |
Working Capital Days | -70 | -59 | -31 | -44 | -53 | -51 | -36 | -35 | -25 | -45 | -29 | -29 |
ROCE % | 8% | 14% | 15% | 16% | 15% | 14% | 11% | 4% | 10% | 11% | 14% | 15% |
Documents
Announcements
-
Report On Transfer Requests Of Physical Shares Re-Lodged Under The Special Window
18 Aug - Report dated Aug 18, 2025: no physical share transfer re-lodgements under SEBI special window July 7-31, 2025.
- Announcement under Regulation 30 (LODR)-Investor Presentation 6 Aug
- Announcement under Regulation 30 (LODR)-Newspaper Publication 6 Aug
-
Announcement under Regulation 30 (LODR)-Credit Rating
6 Aug - CARE reaffirms Artemis Medicare's bank facilities rating at CARE A; Stable, amount enhanced to ₹427.90 crore.
-
Announcement under Regulation 30 (LODR)-Press Release / Media Release
5 Aug - Q1 FY26: Revenue up 14.4%, EBITDA up 19.1%, net profit up 28.2%, new beds added, strategic expansions underway.
Annual reports
Concalls
-
Aug 2025TranscriptNotesPPT
-
May 2025TranscriptNotesPPT
-
Feb 2025TranscriptNotesPPT
-
Nov 2024TranscriptNotesPPT
-
Aug 2024TranscriptNotesPPT
-
May 2024TranscriptNotesPPT
-
Feb 2024TranscriptNotesPPT
-
Feb 2024TranscriptNotesPPT
-
Nov 2023TranscriptNotesPPT
-
Aug 2023TranscriptNotesPPT
-
May 2023TranscriptNotesPPT
-
Feb 2023TranscriptNotesPPT
-
Nov 2022TranscriptNotesPPT
Geographical Revenue Break-up 9MFY24:[1]
Domestic : ~76%
Outside India : ~24%